Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

151.40 +0.28 (+0.19%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

51 52 Next >

Price Over Earnings Overview: Gilead Sciences ↗

July 17, 2023

Via Benzinga

Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash ↗

July 17, 2023

These stocks are built to withstand a bear market.

Via The Motley Fool

FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment ↗

July 14, 2023

The FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using Veklury (remdesivir) in COVID-19 patients with severe renal impairment,

Via Benzinga

7 Tech Stocks to Watch on July 14 ↗

July 12, 2023

Tech stocks are on the rise today ahead of the upcoming Nasdaq 100 rebalancing, the changes for which will be announced this Friday, July 14.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 12, 2023

Via Benzinga

This Is What Whales Are Betting On Gilead Sciences ↗

June 30, 2023

Via Benzinga

Looking Into Gilead Sciences's Recent Short Interest ↗

June 29, 2023

Via Benzinga

Gilead Sciences' Debt Overview ↗

June 29, 2023

Via Benzinga

Ominous Death Cross Forms On Gilead Sciences's Chart ↗

June 28, 2023

Via Benzinga

Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target? ↗

July 10, 2023

Read the latest report on NanoViricides here.

Via Benzinga

Is Johnson & Johnson Stock a Buy Now? ↗

July 09, 2023

Some businesses never go out of style.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy In July ↗

July 05, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

Via InvestorPlace

NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment ↗

July 05, 2023

Read the latest report on NanoViricides here.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 30, 2023

Via Benzinga

Expert Ratings for Gilead Sciences ↗

June 23, 2023

Via Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today ↗

June 22, 2023

Via Benzinga

Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

June 06, 2023

Via Benzinga

Amgen Inc. Dividend Stock Analysis ↗

June 30, 2023

The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years.

Via Talk Markets

2 Low-Priced Stocks That Could Make You Richer ↗

June 26, 2023

These two low-priced healthcare stocks could skyrocket within the next 12 months.

Via The Motley Fool

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

June 23, 2023

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

Via News Direct

Gilead's Chronic Hepatitis Delta Infection Treatment Shows Sustained Efficacy, Safety Profile At Two Years ↗

June 23, 2023

Gilead Sciences Inc (NASDAQ: GILD) announced Week 96 results from the MYR301 Phase 3 clinical trial evaluating bulevirtide for

Via Benzinga

Alleged Industrial Espionage Makes an Interesting Story ↗

June 21, 2023

We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.

Via The Motley Fool

2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

June 21, 2023

Gilead and Regeneron Pharmaceuticals both had triple-digit percentage growth over the past decade.

Via The Motley Fool

Arcellx, A Top 5% Biotech, Dives After A 'Perfect Storm' Leads To A Patient's Death ↗

June 20, 2023

A patient died in Arcellx's multiple myeloma drug study. But the underlying factors are complex.

Via Investor's Business Daily

Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls ↗

June 20, 2023

The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for

Via Benzinga

How to Retire Rich: Biotech Stocks Edition ↗

June 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

Via InvestorPlace

5 Stocks to Buy With Explosive 500% Potential ↗

June 12, 2023

Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

2 Top Biotech Stocks to Buy in June ↗

June 09, 2023

Both companies have solid therapy franchises and continue to expand their horizons.

Via The Motley Fool

3 Biotech Stocks That Could Skyrocket in the Next 12 Months ↗

June 07, 2023

These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

Via InvestorPlace

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gilead Sciences (NQ:GILD)

Headline News about Gilead Sciences

Starting at $3.75/week.

Subscribe Today